464 filings
Page 5 of 24
424B5
0dk29um64raz200330fp
30 Dec 20
Prospectus supplement for primary offering
4:36pm
8-K
vy6k38 r0k
21 Dec 20
Other Events
4:34pm
8-K
tzad6h 34er2gu73
11 Dec 20
Other Events
4:11pm
8-K
usmsms5z3adk5 7qomk
10 Nov 20
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
4:31pm
8-K
afds jxs97zoux25c
13 Aug 20
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:36pm
424B3
u9o56z3
10 Aug 20
Prospectus supplement
7:03am
EFFECT
5l27buo
10 Aug 20
Notice of effectiveness
12:15am
CORRESP
hhydnqtgux2t8su
5 Aug 20
Correspondence with SEC
12:00am
UPLOAD
o4g6wtmg 4bygph0j2i
5 Aug 20
Letter from SEC
12:00am
8-K
o9kn0t
3 Aug 20
Submission of Matters to a Vote of Security Holders
4:58pm
8-K
sqoa6 211qd1ll919waq
27 Jul 20
Lumos Pharma Announces Sale of Priority Review Voucher
4:31pm
RW
sjz0x7fz
10 Jul 20
Registration withdrawal request
4:08pm
8-K
n74fbi3 lh
9 Jun 20
Other Events
5:07pm